Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement.

Dimopoulos MA, Hillengass J, Usmani S, Zamagni E, Lentzsch S, Davies FE, Raje N, Sezer O, Zweegman S, Shah J, Badros A, Shimizu K, Moreau P, Chim CS, Lahuerta JJ, Hou J, Jurczyszyn A, Goldschmidt H, Sonneveld P, Palumbo A, Ludwig H, Cavo M, Barlogie B, Anderson K, Roodman GD, Rajkumar SV, Durie BG, Terpos E.

J Clin Oncol. 2015 Feb 20;33(6):657-64. doi: 10.1200/JCO.2014.57.9961. Epub 2015 Jan 20.

PMID:
25605835
2.

Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.

Dutoit JC, Vanderkerken MA, Verstraete KL.

Eur J Radiol. 2013 Sep;82(9):1444-52. doi: 10.1016/j.ejrad.2013.04.012. Epub 2013 May 28.

PMID:
23726124
3.

The Role of Imaging in the Treatment of Patients With Multiple Myeloma in 2016.

Terpos E, Dimopoulos MA, Moulopoulos LA.

Am Soc Clin Oncol Educ Book. 2016;35:e407-17. doi: 10.14694/EDBK_159074. Review.

4.

International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.

Dimopoulos M, Terpos E, Comenzo RL, Tosi P, Beksac M, Sezer O, Siegel D, Lokhorst H, Kumar S, Rajkumar SV, Niesvizky R, Moulopoulos LA, Durie BG; IMWG.

Leukemia. 2009 Sep;23(9):1545-56. doi: 10.1038/leu.2009.89. Epub 2009 May 7. Review.

PMID:
19421229
5.

Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma.

Hillengass J, Fechtner K, Weber MA, Bäuerle T, Ayyaz S, Heiss C, Hielscher T, Moehler TM, Egerer G, Neben K, Ho AD, Kauczor HU, Delorme S, Goldschmidt H.

J Clin Oncol. 2010 Mar 20;28(9):1606-10. doi: 10.1200/JCO.2009.25.5356. Epub 2010 Feb 22.

PMID:
20177023
6.

[Imaging in smoldering (asymptomatic) multiple myeloma. Past, present and future].

Bhutani M, Landgren O.

Radiologe. 2014 Jun;54(6):572, 574-81. doi: 10.1007/s00117-014-2694-7. German.

PMID:
24927659
7.

A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.

Zamagni E, Nanni C, Patriarca F, Englaro E, Castellucci P, Geatti O, Tosi P, Tacchetti P, Cangini D, Perrone G, Ceccolini M, Brioli A, Buttignol S, Fanin R, Salizzoni E, Baccarani M, Fanti S, Cavo M.

Haematologica. 2007 Jan;92(1):50-5.

8.

Screening whole spine magnetic resonance imaging in multiple myeloma.

Wight J, Stillwell A, Morris E, Grant B, Lai HC, Irving I.

Intern Med J. 2015 Jul;45(7):762-5. doi: 10.1111/imj.12789.

PMID:
25870934
9.

[Contribution of magnetic resonance to the differential diagnosis of a collapsed vertebra in a patient with multiple myeloma].

Sanz L, Bladé J, Olondo M, Rozman M, Mercader JM, Rozman C, Montserrat E.

Sangre (Barc). 1998 Feb;43(1):77-81. Spanish.

PMID:
9577186
10.

Role of MRI for the diagnosis and prognosis of multiple myeloma.

Baur-Melnyk A, Buhmann S, Dürr HR, Reiser M.

Eur J Radiol. 2005 Jul;55(1):56-63. Review.

PMID:
15950101
11.

18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.

Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, Catalano L, Liuzzi R, Rotoli B, Del Vecchio S, Pace L, Salvatore M.

J Nucl Med. 2008 Feb;49(2):195-200. doi: 10.2967/jnumed.107.045641. Epub 2008 Jan 16.

12.

[Aspects and role of spinal MRI in the assessment of solitary plasmacytoma and multiple myeloma. Apropos of 11 cases].

Lafforgue P, Clairet D, Chagnaud C, Toussirot E, Daumen-Legre V, Schiano A, Bayle O, Kasbarian M, Acquaviva PC.

Rev Rhum Mal Osteoartic. 1992 May;59(5):317-26. French.

PMID:
1411192
13.

[Value of magnetic resonance imaging in myeloma].

Bellaïche L, Laredo JD.

Presse Med. 1994 Feb 19;23(7):315-7. Review. French.

PMID:
8208689
14.

[Radiological diagnostics of multiple myeloma].

D'Anastasi M, Grandl S, Reiser MF, Baur-Melnyk A.

Radiologe. 2014 Jun;54(6):556-63. doi: 10.1007/s00117-013-2628-9. German.

PMID:
24927658
15.

[Neurologic sequelae of bone changes in multiple myeloma and its therapy].

Basić-kes V, Basić-Jukić N, Kes P, Demarin V, Labar B.

Acta Med Croatica. 2002;56(3):103-7. Review. Croatian.

PMID:
12630341
16.

[Multiple myeloma: current recommendations for imaging].

Hillengass J, Delorme S.

Radiologe. 2012 Apr;52(4):360-5. doi: 10.1007/s00117-011-2257-0. German.

PMID:
22441560
17.

Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma.

Merz M, Hielscher T, Wagner B, Sauer S, Shah S, Raab MS, Jauch A, Neben K, Hose D, Egerer G, Weber MA, Delorme S, Goldschmidt H, Hillengass J.

Leukemia. 2014 Sep;28(9):1902-8. doi: 10.1038/leu.2014.75. Epub 2014 Feb 18.

PMID:
24535407
18.

Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolyses in patients with monoclonal plasma cell disease.

Wolf MB, Murray F, Kilk K, Hillengass J, Delorme S, Heiss C, Neben K, Goldschmidt H, Kauczor HU, Weber MA.

Eur J Radiol. 2014 Jul;83(7):1222-1230. doi: 10.1016/j.ejrad.2014.02.008. Epub 2014 Feb 22.

PMID:
24793843
19.

The role of imaging techniques in the management of multiple myeloma.

Zamagni E, Cavo M.

Br J Haematol. 2012 Dec;159(5):499-513. doi: 10.1111/bjh.12007. Epub 2012 Aug 11. Review.

PMID:
22881361
20.

Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging.

Bäuerle T, Hillengass J, Fechtner K, Zechmann CM, Grenacher L, Moehler TM, Christiane H, Wagner-Gund B, Neben K, Kauczor HU, Goldschmidt H, Delorme S.

Radiology. 2009 Aug;252(2):477-85. doi: 10.1148/radiol.2522081756.

PMID:
19703885

Supplemental Content

Support Center